2022-12-19

Casestory

A major biopharmaceutical company signed an Alfa Laval Service Agreement to prevent costly production losses after experiencing unplanned downtime of critical high-speed separators. The result?

More uptime improved operational reliability during harvesting and increased yield while ensuring patient safety.

Click here to download a copy

 

 

Tags

All
pharma640

Related content: